title: External beam radiotherapy for localized prostate cancer.
abstract: Radiotherapy (XRT) is a curative treatment option for prostate cancer (PCa). Recent XRT technologies allow higher dose therapy that lead to increased local control with less adjacent tissue damage. Additionally, receiving neo-adjuvant or adjuvant hormonotherapy (HT) during radiation therapy increases the curative effect. The aim of this paper is to review the current literature and guidelines on external beam radiation therapy for PCa. However, brachytherapy and radiosurgery, a recently evolving relatively new technology for the radiotherapeutic management of localized PCa, are beyond the scope of this paper.
authors.forename: Hasan
authors.initials: H
authors.lastname: Yilmaz
authors.forename: Gorkem
authors.initials: G
authors.lastname: Aksu
authors.affiliation: Kocaeli University, School of Medicine, Department of Urology, Kocaeli, Turkey.
authors.forename: Ozdal
authors.initials: O
authors.lastname: Dillioglugil
mesh_terms: D000230:Adenocarcinoma / Q000532:radiotherapy*; D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D059186:Chemoradiotherapy, Adjuvant; D006801:Humans; D008297:Male; D018579:Patient Selection; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011829:Radiation Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D018714:Radiotherapy, Adjuvant
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal